Page 19 - Crispr News Today

With biotech partners including Moderna, ElevateBio brings deep lab expertise to the emerging race for life-saving gene and cell therapies.

SNIPR Biome ApS ("SNIPR"), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work on  SNIPR001, the first CRISPR-armed phage therapeutic developed to specifically target and remove E. coli, including antibiotic-resistant strains, in the human gastrointestinal tract.

Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, discusses how CRISPR technology has seen success and potential areas for future application.

The education project will ultimately address educational disparities and develop agricultural and science literacy in Hawaiʻi.

Scientists said they have designed nanoparticle sensors that could diagnose early-stage cancer through a simple urine tests on a strip of paper.

With a sizable grant from the TED Audacious Project, scientists at UC Davis, UC Berkeley and UC San Francisco are using the Nobel-Prize-winning gene editing tool known as CRISPR to attempt to reduce the methane released by dairy cows.

Vertex Pharmaceuticals and CRISPR Therapeuticss one-dose gene editing therapy for sickle cell disease would be cost effective if priced at up to $1.9 million, an influential US drug pricing group said on Wednesday.

Mutations in the identical genes lead to diverse subtypes of tumors in different individuals. Scientists have identified a new way to generate tumor subtypes.

In the face of safety risks, experts have tightened the reins on heritable genome editing—but haven’t ruled out using it someday.

A new CRISPR technique was employed by Chinese scientists to successfully restore vision in mice. Researchers in China have announced a groundbreaking discovery in the treatment of retinitis pigmentosa, a leading cause of blindness in humans.